Dual-target BCMA-CD19 CAR-T Cell Therapy for RR/MM With Extramedullary Infiltration

Clinical trial NCT07003555 · RECRUITING

Trial details

NCT number: NCT07003555
Sponsor: Beijing GoBroad Hospital
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Relapsed or Refractory Multiple Myeloma (RRMM)

Start date: 2025-05-25
Primary completion: 2027-05-25
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.